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Background: Intrauterine growth restriction (IUGR) is the single largest contributing factor to perinatal mortality in
non-anomalous fetuses. Advances in antenatal and neonatal critical care have resulted in a reduction in neonatal
deaths over the past decades, while stillbirth rates have remained unchanged. Antenatal detection rates of fetal
growth failure are low, and these pregnancies carry a high risk of perinatal death.
Methods: The Prospective Observational Trial to Optimize Paediatric Health in IUGR (PORTO) Study recruited 1,200
ultrasound-dated singleton IUGR pregnancies, defined as EFW <10th centile, between 24+0 and 36+6 weeks
gestation. All recruited fetuses underwent serial sonographic assessment of fetal weight and multi-vessel Doppler
studies until birth. Perinatal outcomes were recorded for all pregnancies. Case records of the perinatal deaths from
this prospectively recruited IUGR cohort were reviewed, their pregnancy details and outcome were analysed
descriptively and compared to the entire cohort.
Results: Of 1,116 non-anomalous singleton infants with EFW <10th centile, 6 resulted in perinatal deaths including
3 stillbirths and 3 early neonatal deaths. Perinatal deaths occurred between 24+6 and 35+0 weeks gestation
corresponding to birthweights ranging from 460 to 2260 grams. Perinatal deaths occurred more commonly in
pregnancies with severe growth restriction (EFW <3rd centile) and associated abnormal Doppler findings resulting
in earlier gestational ages at delivery and lower birthweights. All of the described pregnancies were complicated
by either significant maternal comorbidities, e.g. hypertension, systemic lupus erythematosus (SLE) or diabetes, or
poor obstetric histories, e.g. prior perinatal death, mid-trimester or recurrent pregnancy loss. Five of the 6 mortalities
occurred in women of non-Irish ethnic backgrounds. All perinatal deaths showed abnormalities on placental
histopathological evaluation.
Conclusions: The PNMR in this cohort of prenatally identified IUGR cases was 5.4/1,000 and compares favourably
to the overall national rate of 4.1/1,000 births, which can be attributed to increased surveillance and timely
delivery. Despite antenatal recognition of IUGR and associated maternal risk factors, not all perinatal deaths can
be prevented.
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Suboptimal intrauterine growth affects up to 10% of
pregnancies and confers an increased risk of perinatal
morbidity and mortality. The perinatal outcome of
IUGR fetuses is largely dependent on the severity of
growth restriction with those below the 3rd centile and/
or abnormal umbilical artery Doppler measurements at
greatest risk of adverse outcome [1]. Other important
prenatal determinants of perinatal outcome are gesta-
tional age at delivery and birthweight, with best pros-
pects of morbidity-free survival to hospital discharge
at weights over 800 grams and gestational ages over
29 weeks [2].
Advances in obstetrical and critical neonatal care are
reflected in a substantial decrease in the overall perinatal
mortality rate (PNMR) in high income countries. While
this effect is mainly seen in a reduction of early neonatal
deaths, stillbirth rates have remained largely unchanged
over the past years [3,4]. In addition to congenital abnor-
malities, more recent reports have identified fetal growth
restriction as one of the main contributors to perinatal
mortality [5].
Ireland consistently reports highest birth rates among
European countries with 16.8 births per 1,000 popula-
tion (compared to 13.0/1,000 in the UK and 8.3/1,000 in
Germany) [6]. In 2011, there were 74,265 births and 456
perinatal deaths in Ireland [7]. Stillbirths and early neonatal
deaths accounted for 70% (n = 318) and 30% (n = 138) of
perinatal deaths respectively, corresponding to a PNMR of
6.1/1,000 births. Of the 456 perinatal deaths, 155 (34%)
were attributed to congenital structural or genetic abnor-
malities (corrected PNMR 4.1/1,000). Over 50% of infants
affected by perinatal deaths in 2011 were identified as
having birthweights below the 10th customised centile and
only 30% of those were suspected antenatally [7].
Current antenatal detection rates of IUGR are re-
ported at 25 to 36% [8,9]. Therefore, a preventative
strategy to reduce stillbirths is to improve the antenatal
detection of fetal growth failure. The risk of stillbirth in
pregnancies with prenatally identified IUGR is 1% (9.7/
1,000 births). Pregnancies with unrecognized IUGR
carry an over 8-fold increased risk of stillbirth (SB)
when compared to pregnancies without IUGR (19.8
versus 2.4/1,000 births) [5]. Whenever IUGR is diag-
nosed prenatally, increased surveillance and timely de-
livery aims to improve perinatal outcome in IUGR,
balancing the risk of antepartum stillbirth by remaining
in utero and iatrogenic prematurity potentially causing
significant morbidity or neonatal death by too early
intervention.
This paper describes the 6 perinatal mortality cases
which occurred in the setting of a multicentre prospect-
ive study of 1,200 pregnancies with prenatally identified
IUGR defined as EFW below the 10th centile [1,10].Methods
The Prospective Observational Trial to Optimise Paediatric
Health in IUGR (PORTO) is a national prospective study
conducted at seven largest maternity units in Ireland.
Intrauterine growth restriction (IUGR) was defined as
EFW below the 10th centile based on sonographic mea-
surements of the fetal head circumference (HC), bi-parietal
diameter (BPD), abdominal circumference (AC) and femur
length (FL) according to population-based growth stan-
dards (Hadlock-4) [11]. Between January 2010 and June
2012, the PORTO Study recruited 1,200 ultrasound-dated
singleton pregnancies between 24+0 and 36+6 weeks’ and
an EFW equal or greater than 500 grams. Fetuses with
congenital structural or chromosomal abnormalities were
excluded from the final analysis. Ethical approval was ob-
tained at each participating site, and a written informed
consent was given by all study participants.
Women with IUGR pregnancies underwent serial sono-
graphic evaluation of fetal weight at 2-weekly intervals
until birth including evaluation of amniotic fluid volume
and multi-vessel Doppler assessment. Details on Doppler
assessment and reference ranges are described in a previ-
ous publication [10]. In cases of absent (AEDF) or reversed
end-diastolic (REDF) in the UA, the patient was admitted
to hospital and daily electronic fetal heart rate (FHR) moni-
toring with computerised analysis of short term variation
according to Dawes/Redman criteria (Sonicaid Team Fetal
Monitor with FHR analysis, MDI Medicare, Ireland) was
carried out. Corticosteroids to promote fetal lung matur-
ation and reduce perinatal morbidity were administered as
a single course between 24 and 36 weeks’ gestation if deliv-
ery was likely within one week. Given that the PORTO
Study was observational and descriptive in nature, there
were no pre-specified management or delivery criteria and
all decisions were made by the lead clinician managing
each case reflecting real world clinical practice. All study
participants received the same surveillance (2-weekly sono-
gram or more frequently as deemed necessary) with the
aim to describe differences in outcome. There was however
general agreement among clinicians to deliver AEDF cases
no later than 34 weeks’ gestation.
The perinatal mortality rate (PNMR) was calculated by
the number of stillbirths and neonatal deaths per 1,000
live births and stillbirths (all births were ≥24 weeks ges-
tation and weighed ≥500 grams). The PNMR was cor-
rected for congenital abnormalities.
All cases were prospectively recruited and medical re-
cords of all mortalities were reviewed retrospectively for
this descriptive analysis. Comparisons were made to the
entire cohort, and demographic and pregnancy course
and outcome data were recorded along with a review of
placental histopathology.
Placental abnormalities were categorised according
to Redline criteria [12] into villous developmental
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normal placental shape/position, chorangiosis), maternal
vascular pathology, fetal vascular pathology and inflam-
matory lesions (acute chorioamnionitis, chronic villitis of
unknown aetiology). Maternal vascular injuries include in-
farction, retroplacental haemorrhage and increased perivil-
lous fibrinoid deposition (maternal floor infarction). Fetal
vascular injuries include true cord knots, cord hypercoil-
ing, abnormal cord insertion, single umbilical artery and
fetal thrombotic vasculopathy.
Due to the small sample size, formal statistical com-
parisons and modelling (such as logistic regression) are
underpowered. Therefore, statistically non-significant
findings have the potential to be misleading. Further-
more, due to the biases associated with retrospective se-
lection of controls and the potential for overmatching
with a small case-set, the mortalities are presented as a
case-series rather than as a case-control study. Conse-
quently, the cases have been described individually (as
shown in Figure 1), where each pregnancy/mortality
case has its own context.
Results
There were 6 mortalities including 3 stillbirths (SB) and
3 early neonatal deaths (NND) within the entire cohortFigure 1 Case study of non-anomalous singleton PORTO mortalities (
IUD intrauterine death; AEDF absent end-diastolic flow; UA umbilical artery
previous; APH antepartum haemorrhage; BW birthweight; IOL induction ofof 1,116 non-anomalous singleton pregnancies complet-
ing the study protocol. This corresponds to a PNMR of
5.4/1,000. The maternal demographics, baseline charac-
teristics and sonographic findings are described in
Table 1. Not surprisingly, perinatal deaths occurred
more commonly in pregnancies with severe growth re-
striction (EFW <3rd centile) and associated abnormal
Doppler findings resulting in earlier gestational ages at
delivery and lower birthweights.
Stillbirths occurred at gestational ages between 24+6 and
31+3 weeks with birthweights ranging from 460 to 740
grams (mean 607 grams). All stillbirths had estimated
weights below the 3rd centile and AEDF in the umbilical
artery, and they occurred during inpatient care. The
median time from study recruitment to diagnosis of intra-
uterine demise was 12 days (range 0-45 days). One woman
had placenta praevia associated with recurrent antepartum
haemorrhages and one woman had severe pre-eclampsia
on the background of essential hypertension. Two women
had previous pregnancies that resulted in perinatal deaths
(one NND due to abruption at 36 weeks, one with unex-
plained SB at term), and all women with stillbirths were
non-Irish nationals.
All cases of neonatal deaths were delivered by emer-
gency caesarean section between 27+4 and 35+0 weeksn = 6). SB stillbirth; NND neonatal death, D day of life; Dx diagnosis;
; Obs Hx obstetric history; PET pre-eclampsia; Gest gestational; Prev
labour; CTG cardiotocograph.
Table 1 Maternal demographics, baseline characteristics
and sonographic findings
Perinatal
mortalities
(n = 6)
Alive at hospital
discharge
(n = 1,110)
Maternal age 31.5 ± 6.3 29.9 ± 6.0
Advanced maternal age >35 years 2 (33%) 225 (20%)
Nulliparity 2 (33%) 298 (45%)
Smoker 0 261 (24%)
BMI >30 kg/m2 3 (50%) 122 (11%)
Hypertension/Pre-eclampsia 1 (17%) 148 (13%)
Placental abruption 2 (33%) 14 (1%)
Assisted reproductive techniques 0 16 (1%)
Maternal diabetes 1 (17%) 17 (2%)
GA at enrolment 26.1 ± 2.7 30.1 ± 3.9
GA at delivery 29.4 ± 3.8 37.8 ± 2.9
Last scan EFW <3rd centile 5 (83%) 421 (38%)
Last scan EFW <10th centile 6 (100%) 834 (75%)
Last scan EFW <10th customised
centile
6 (100%) 794 (72%)
Birthweight <3rd centile 4 (67%) 507 (46%)
Abnormal UA Doppler
(PI >95th, AEDF)
4 (67%) 508 (46%)
AEDF in the UA 4 (68%) 72 (6%)
PI, pulsatility index; UA, umbilical artery; AEDF, absent end-diastolic flow; EFW,
estimated fetal weight; GA, gestational age.
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and 2260 grams (mean 1147 grams). The median time of
antenatal surveillance was 25 days (range 24-34 days).
As outlined in Figure 1, delivery #4 was for clinical chor-
ioamnionitis due to prolonged preterm rupture of mem-
branes from 12 weeks gestation. The neonate died on
day 1 of life due to pulmonary hypoplasia. A prolonged
bradycardia on antenatal fetal heart rate monitoring
prompted delivery of a severely growth restricted infant
<3rd centile and umbilical artery AEDF in case #5. The
mother received inpatient care for active SLE and the
neonate died on day 3 of life. Neonatal death #6 resulted
from a recurrent placental abruption at 35 weeks gesta-
tion one week prior to her planned delivery; in this case
neonatal intensive care was withdrawn after 4 days due
to grade 3 hypoxic ischemic encephalopathy (HIE) and
multi-organ failure.
Figure 1 summarises the obstetric history and mater-
nal risk factors and outlines the pregnancy course in de-
tail, including information on delivery indication and
outcome. The table also shows information derived from
post-mortem examination, cord and placental histo-
pathological evaluation. All of the described pregnancies
were complicated by either significant maternal comor-
bidities, in particular hypertension, SLE or diabetes, orpoor obstetric histories. Maternal histories were signifi-
cant for previous IUGR, recurrent or late pregnancy loss,
NND or SB. Two thirds of patients (n = 4) had a poor ob-
stetric history including 3 women with term mortalities in
prior pregnancies (2 placental abruptions and 1 unex-
plained stillbirth at term) and 1 woman with a history of
recurrent first trimester miscarriages. Four of the 6 mor-
talities occurred in women of non-Irish ethnic back-
grounds. All cases showed placental or cord pathologies
including maternal and fetal vascular injuries, placental
developmental abnormalities or inflammatory lesions.
The majority of perinatal deaths (n = 5) were associated
with an EFW< 3rd centile and abnormal UA Doppler velo-
cimetries in the umbilical artery. The 2 perinatal deaths
with normal UA Doppler were attributed to pulmonary
hypoplasia and histologically confirmed chorioamnionitis
due to prolonged preterm rupture of the membranes
which and to a recurrent placental abruption at 35 weeks
gestation.
Discussion
The striking and common feature of all perinatal death
cases in our study is that they more commonly occurred
in non-Irish national women attending for antenatal care
with poor obstetric histories and coexistent maternal co-
morbidities. These findings are in agreement with other
reports which found that ethnic minorities are an over-
represented group among mothers who experience peri-
natal deaths [7,13]. In particular, women with a history
of adverse pregnancy outcomes, such as recurrent preg-
nancy loss, stillbirth or perinatal deaths, are at higher
risk of recurrent adverse outcomes with fewer than 25%
pregnancies resulting in surviving infants [14].
Perinatal deaths occurred more commonly among in-
fants with severe growth restriction and associated abnor-
mal umbilical artery Doppler values which highlights the
fact that fetuses with EFW <3rd centile and/or abnormal
UA Doppler are a greater risk of poor perinatal outcome
therefore making this a more appropriate cut-off for the
definition of pathological growth restriction [1].
A detailed evaluation of the cord and placenta is useful
in determining the underlying causes which have led to
an IUGR diagnosis. Histopathological examination was
carried out for all perinatal deaths in our study and
interestingly showed abnormal findings in 100% of cases
including maternal and fetal vascular injuries, placental
developmental abnormalities or inflammatory lesions.
Unfortunately, there are no specific antenatal screening
or preventative strategies for cord and placental abnor-
malities. Together with maternal factors, this informa-
tion can however be utilised when caring for women in
a subsequent pregnancies.
The PNMR in this IUGR cohort compares favourably
to the national corrected PNMR of 4.1/1,000. The
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IUGR fetuses can be explained by (i) the intensive pre-
natal surveillance within a research setting attributed to
the Hawthorne effect, which has been described as a
confounding factor for performance in clinical observa-
tional studies and (ii) the exclusion of pregnancies at
most severe spectrum of disease (i.e. EFW <500 grams
at or over 24 weeks gestation). Despite the antenatal
recognition of maternal risk factors and diagnosis of
IUGR with initiation of increased surveillance and in-
patient management, not all perinatal deaths in our
study were prevented. Some of these deaths occurred
during inpatient care or were due to unforeseen acute
complications such as placental abruption, antepartum
haemorrhage in the presence of placenta praevia or
acute chorioamnionitis. However the increased surveil-
lance certainly benefited the majority of women and ba-
bies enrolled in PORTO reflected in the low PNMR in
this high risk cohort which was comparable to the over-
all national rate.
A limitation of our study concerns the inability to
comment on antenatal detection rates of IUGR in Irish
maternity units as data on this was not recorded. Pre-
natal recognition of IUGR remains the main challenge inFigure 2 Fetal growth restriction–management algorithm.daily obstetric practice. Current detection rates of IUGR
in the antenatal setting are at best 36% and future re-
search needs to urgently focus on how we can improve
these detection rates. Clinical examination, abdominal
palpation and fundal height measurement have limited
accuracy in identifying IUGR prenatally and serial ultra-
sound scanning from 26 to 28 weeks of gestation has
been proposed in patients with risk factors [15]. A care
model whereby every pregnant patient receives an ultra-
sound scan at least 4 weekly intervals would improve
identification of growth failure based on population and
customised growth standards. Given that IUGR can also
occur in infants born with birthweights above the 10th
centile cut-off, this approach would also allow to comment
on growth trajectories which have been identified as an
important factor in the prediction of morbidity and mor-
tality outcomes [16]. The relevance to clinical practice in
reducing perinatal morbidity and mortality could be the
subject of future research studies comparing various
models of antenatal care. This will impact on resource is-
sues, increase obstetric intervention but no doubt will
have an impact on the antenatal detection and reduction
in perinatal deaths. At the present time, we propose a
management algorithm outlined in Figure 2 [17].
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Fetal growth restriction is the single most important con-
tributor to perinatal mortality in non-anomalous fetuses
[5]. Significant research efforts have gone into improving
the diagnosis and definition of IUGR, surveillance and
antenatal management, however uncertainties regarding
the optimal timing of delivery in IUGR persist.
Vigilance towards antenatal risk factors for poor
pregnancy outcome is important for the optimal man-
agement of IUGR pregnancies. The focus of future
research needs to urgently address how we can im-
prove the antenatal detection of IUGR. Prenatal re-
cognition of IUGR dramatically improves pregnancy
outcomes allowing for close monitoring and timely
delivery. Nevertheless, even if recognised, not all peri-
natal deaths can be prevented.
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